Eligibility
18+
Female
What conditions do you have?
Select
Study Summary
The purpose of this study is to test an evidence-based intervention designed to increase adherence to systemic therapy in Black women compared to enhanced usual care.
Eligible Conditions
- Breast Cancer
Treatment Effectiveness
Effectiveness Progress
Other trials for Breast Cancer
Study Objectives
3 Primary · 4 Secondary · Reporting Duration: 36 Months
36 Months
Assess Perceived Involvement in Care: PCC Outcomes - Level of Engagement in Decision Making
Assess Perceived Involvement in Care: PCC Outcomes - Perceptions of Doctor Behaviors by determining a more patient-centered encounter vs a more biomedically focused encounter.
Assess Perceived Involvement in Care: PCC Outcomes - Perceptions of Patient Behaviors by determining Perceptions of Doctor Behaviors by determining a more patient-centered encounter vs a more biomedically focused encounter
Assessing Study Adherence Behaviors- Delay of Adjuvant or Endocrine Therapy.
Assessing Study Adherence Behaviors- Initiation
Assessing Study Adherence Behaviors- Overall Chemotherapy Adherence
Determine Process and Implementation Outcomes
Trial Safety
Safety Progress
Other trials for Breast Cancer
Trial Design
2 Treatment Groups
Enhanced Usual Care
1 of 2
Sisters Informing Sisters Sessions
1 of 2
Active Control
Experimental Treatment
460 Total Participants · 2 Treatment Groups
Primary Treatment: SIS TALK Back Intervention · No Placebo Group · N/A
Sisters Informing Sisters Sessions
Behavioral
Experimental Group · 1 Intervention: SIS TALK Back Intervention · Intervention Types: BehavioralEnhanced Usual CareNoIntervention Group · 1 Intervention: Enhanced Usual Care · Intervention Types:
Trial Logistics
Trial Timeline
Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 36 months
Closest Location: Massey Cancer Center · Richmond, VA
2009First Recorded Clinical Trial
8 TrialsResearching Breast Cancer
63 CompletedClinical Trials
Who is running the clinical trial?
Virginia Commonwealth UniversityLead Sponsor
609 Previous Clinical Trials
341,925 Total Patients Enrolled
17 Trials studying Breast Cancer
1,922 Patients Enrolled for Breast Cancer
Georgetown UniversityOTHER
315 Previous Clinical Trials
120,365 Total Patients Enrolled
33 Trials studying Breast Cancer
12,910 Patients Enrolled for Breast Cancer
Vanessa B Sheppard, Ph.DPrincipal InvestigatorVirginia Commonwealth University
Eligibility Criteria
Age 18+ · Female Participants · 8 Total Inclusion Criteria
Mark “yes” if the following statements are true for you:You are eligible for chemotherapy or endocrine therapy according to NCCN guidelines, but have not initiated systemic therapy.
You are able to provide meaningful consent as determined by trained study personnel and/or a member of the patient's care team.
About The Reviewer
Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.
Top Oncology Trials
Top Clinical Trials in Cities
Relevant Clinical Trials
Unbiased Results
We believe in providing patients with all the options.Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.Back to top
Conditions
Cancer Related
Treatments